Experimental models have shown that CYLD loss promotes aggressive behavior in various malignancies, including cutaneous SCC [40], pancreatic carcinoma [41], and hepatocellular carcinoma [39]. The gene discussed is CYLD; the disease is hepatocellular carcinoma.